vaxigrip: Clinical Trials

17 trials of vaxigrip, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 3 unknown, 2 not yet recruiting. 17 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 417Completed 12, Unknown 3, Not yet recruiting 2

Follow vaxigrip: new trials by email Literature Review of vaxigrip trials Research Report on vaxigrip

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity of Standard-Dose Versus High-Dose Influenza Vaccines in Older Adults in Singapore
High-dose influenza vaccine, Standard-dose influenza vaccine - Influenza
Phase 4Not yet recruitingTan Tock Seng Hospital1502026-11-012026-10-20
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)
Anflu®, Vaxigrip® - Influenza
Phase 4Not yet recruitingSinovac Biotech Co., Ltd1502026-10-012026-09-21
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
Vaxigrip - Influenza, Obesity
Phase 4UnknownMedical University of Warsaw15002020-09-152024-03-01
Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis
Influenza vaccine, Placebo - Myocardial Infarction, Influenza, Human
Phase 4CompletedOle Frobert, MD, PhD25712016-10-012021-09-22
Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military
Seasonal trivalent influenza vaccine, Anflu®, Seasonal trivalent influenza vaccine, VAXIGRIP, Seasonal trivalent influenza vaccine, Fluarix - Influenza
Phase 4CompletedCenter for Disease Prevention and Control of Beijing Military Region2922014-10-012015-12-29
Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults
Trivalent Inactivated Influenza Vaccine - Influenza, HIV
Phase 4CompletedUniversity of Witwatersrand, South Africa3012014-03-312018-09-05
The Immune Response to Influenza Vaccinations in Elderly Individuals
Vaxigrip® - Influenza
Phase 4CompletedNational University Hospital, Singapore2402013-12-012017-08-30
Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
Intanza, Vaxigrip - Influenza, Human
Phase 4UnknownThe University of Hong Kong1002013-10-012013-10-22
Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women
Trivalent Influenza Vaccine - Influenza
Phase 4CompletedUniversity of Witwatersrand, South Africa1502013-09-012015-01-12
Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women
Trivalent Inactivated Influenza Vaccine - Influenza, Human Immunodeficiency Virus
Phase 4CompletedUniversity of Witwatersrand, South Africa1052013-05-012013-12-11
A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine
Intanza, Vaxigrip - Influenza, Vaccination Site Reactions (HT)
Phase 4CompletedBrenda Coleman8682012-09-012017-04-19
Maternal Flu Vaccine Trial in Bamako, Mali
Inactivated Influenza Vaccine Trivalent Types A and B, Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate Vaccine - Influenza
Phase 4CompletedUniversity of Maryland, Baltimore41932011-09-122019-09-26
Comparison of 4 Influenza Vaccines in Seniors
Agriflu, Fluad, Intanza - Influenza Vaccine
Phase 4CompletedUniversity of British Columbia9532011-07-012015-04-15
Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea
IDflu™: Split virion inactivated influenza vaccine, Vaxigrip®: Split virion inactivated influenza vaccine - Influenza
Phase 4CompletedSanofi Pasteur, a Sanofi Company2402010-10-012018-09-13
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
Inactivated Trivalent Influenza Vaccine, Inactivated polio vaccine (IPV) - Influenza
Phase 4CompletedWayne Sullender, M.D.45982009-09-012013-02-22
Inactivated Influenza Vaccine Effectiveness in Tropical Africa
seasonal trivalent inactivated influenza vaccine, inactivated polio vaccine - Influenza
Phase 4CompletedPATH100002009-05-012013-09-23
Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines
influenza vaccine - Healthy Volunteers
Phase 4UnknownNational Centre for Epidemiology, Hungary852008-11-012010-05-07

Conditions studied

Influenza, Human (17)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Frailty (1)  ·  HIV Infections (1)  ·  Heart Failure (1)  ·  Myocardial Infarction (1)  ·  Obesity (1)  ·  Orthomyxoviridae Infections (1)  ·  Pregnancy Complications, Infectious (1)  ·  Respiratory Tract Infections (1)  ·  Stroke (1)  ·  Tuberculosis (1)

Sponsors

University of Witwatersrand, South Africa (3)  ·  Brenda Coleman (1)  ·  Center for Disease Prevention and Control of Beijing Military Region (1)  ·  Medical University of Warsaw (1)  ·  National Centre for Epidemiology, Hungary (1)  ·  National University Hospital, Singapore (1)  ·  Ole Frobert, MD, PhD (1)  ·  PATH (1)  ·  Sanofi Pasteur, a Sanofi Company (1)  ·  Sinovac Biotech Co., Ltd (1)  ·  Tan Tock Seng Hospital (1)  ·  The University of Hong Kong (1)  ·  University of British Columbia (1)  ·  University of Maryland, Baltimore (1)  ·  Wayne Sullender, M.D. (1)

Countries

China (3)  ·  South Africa (3)  ·  Canada (2)  ·  Singapore (2)  ·  Australia (1)  ·  Bangladesh (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Hungary (1)  ·  India (1)  ·  Latvia (1)  ·  Mali (1)  ·  Norway (1)  ·  Poland (1)  ·  Senegal (1)

Top investigators

Shabir A Madhi, PHD (3)  ·  Aldiouma Diallo, MD (1)  ·  Allison J McGeer, MD, FRCPC (1)  ·  Anand Krishnan, MD (1)  ·  Barnaby E Young, MB BChir, PhD (1)  ·  Brenda L Coleman, PhD (1)  ·  Christine Moore (1)  ·  David W Scheifele, MD (1)  ·  Dongqi Gao, PhD (1)  ·  Joanne M Langley, MD (1)  ·  John C Victor, PhD, MPH (1)  ·  Melissa Barton (1)  ·  Milagritos D Tapia, MD (1)

Results publications

PMID 22872731, PMID 23778938, PMID 24957950, PMID 26529074, PMID 27261067, PMID 29443825, PMID 30455722, PMID 30689757, PMID 31200893, PMID 32379201, PMID 32526188, PMID 32868130, PMID 33165566, PMID 34459211, PMID 40203592

NIH funding

2008 (1)